Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Cash from Operations (2016 - 2025)

MediWound has reported Cash from Operations over the past 13 years, most recently at 3016000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 84.24% year-over-year to 3016000.0; the TTM value through Dec 2025 reached 16121000.0, down 18.33%, while the annual FY2025 figure was 16121000.0, 18.33% down from the prior year.
  • Cash from Operations for Q4 2025 was 3016000.0 at MediWound, up from 3239000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 750000.0 in Q4 2022 and troughed at 5756000.0 in Q2 2025.
  • A 5-year average of 3172400.0 and a median of 3437000.0 in 2023 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: skyrocketed 133.56% in 2022 and later tumbled 806.75% in 2024.
  • Year by year, Cash from Operations stood at 2235000.0 in 2021, then skyrocketed by 133.56% to 750000.0 in 2022, then tumbled by 448.67% to 2615000.0 in 2023, then skyrocketed by 37.4% to 1637000.0 in 2024, then plummeted by 84.24% to 3016000.0 in 2025.
  • Business Quant data shows Cash from Operations for MDWD at 3016000.0 in Q4 2025, 3239000.0 in Q3 2025, and 5756000.0 in Q2 2025.